Cargando…
Development of novel budesonide pellets based on CODES(TM) technology: In vitro/in vivo evaluation in induced colitis in rats
BACKGROUND AND THE PURPOSE OF THE STUDY: Budesonide is the drug of choice for treatment of active inflammatory bowel disease (IBD). The aim of this study was to develop budesonide pellets based on a novel colon drug delivery system (CODES). METHODS: Pellet cores containing lactulose or mannitol were...
Autores principales: | Varshosaz, J., Emami, J., Tavakoli, N., Minaiyan, M., Rahmani, N., Dorkoosh, F., Mahzouni, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232096/ https://www.ncbi.nlm.nih.gov/pubmed/22615647 |
Ejemplares similares
-
Pectin Film Coated Pellets for Colon-targeted Delivery of Budesonide: In-vitro/In-vivo Evaluation in Induced Ulcerative Colitis in Rat
por: Varshosaz, Jaleh, et al.
Publicado: (2012) -
Development and Evaluation of a Novel Pellet-Based Tablet System for Potential Colon Delivery of Budesonide
por: Varshosaz, Jaleh, et al.
Publicado: (2012) -
Colon Delivery of Budesonide Using Solid Dispersion in Dextran for the Treatment and Secondary Prevention of Ulcerative Colitis in Rat
por: Varshosaz, Jaleh, et al.
Publicado: (2010) -
Development and validation of a rapid HPLC method for simultaneous analysis of budesonide and its novel synthesized hemiesters in colon specific formulations
por: Varshosaz, J., et al.
Publicado: (2011) -
Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design
por: Emami, J., et al.
Publicado: (2015)